Six patients with tardive dyskinesia were treated with lithium carbonate
in an open clinical trial. Evaluations using a new tardive dyskinesia
rating scale showed statistically significant improvement in dyskinetic
movements while the patients received lithium. This improvement was
consistently observed in all patients but was relatively small when
compared to the amount of pathology present.